Skip to Content

Association of American Medical Colleges Tomorrow's Doctors, Tomorrow's Cures®

Filter by:

Second Opinion Podcasts

Learn about policy issues important to medical schools and teaching hospitals, with Atul Grover, M.D., Ph.D.



Future innovations in health care and prevention require research across a full spectrum of biomedical science, from basic and translational research to implementation science and comparative effectiveness research. 

AAMC advocates for funding and appropriate regulation by major federal agencies and organizations supporting this research, including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Department of Veterans Affairs (VA).

Ensuring a sustainable research mission is essential to achieve long-term health priorities, develop new therapeutics and preventive measures, focus on patient-centered outcomes, and reduce health disparities. 

We also work to ensure the integrity of biomedical research, especially research involving human subjects, including privacy protections and management of financial conflicts of interest.


Comparative EffectivenessResponsible Conduct of Research
Research with AnimalsStem Cell Research and Regenerative Medicine

News and Updates

NIH Requests Input on Agency-Wide Strategic Plan

July 24, 2015

The National Institutes of Health (NIH) July 22 released a Request for Information (RFI) inviting comments and suggestions on a framework for a five year NIH-wide strategic plan.

Senate Panel Explores Incentives, Obstacles for Developing Cures

July 17, 2015

The Senate Commerce, Science, and Transportation Subcommittee on Space, Science, and Competitiveness July 14 held a hearing titled, “Unlocking the Cures for America’s Most Deadly Diseases.”

House Passes Cures Act

July 10, 2015

The House of Representatives July 10 approved (344-77) the 21st Century Cures Act (H.R. 6). A total of 170 Republicans and 174 Democrats voted for the bill while 70 Republicans and 7 Democrats voted no.

CBO Issues Cost Estimate for 21st Century Cures Act

June 26, 2015

The Congressional Budget Office (CBO) June 23 estimated the cost of implementing the 21st Century Cures Act (H.R. 6) would total $106.4 billion for the 2016-2020 period.

Appropriations Panels Approve HHS Spending Bills

June 26, 2015

The House Appropriations Committee June 24 approved its fiscal year (FY) 2016 Labor-HHS spending bill by a 30-21 vote after rejecting a number of Democratic amendments to restore funding to programs cut by the measure. The Senate Appropriations Committee passed its version of the bill the following day by a 16-14 vote.

On Government Affairs

Research Spectrum

Testimony and Correspondence